News Roundup March 6-March 10
Your weekly roundup of the latest news from Drug Topics®.
Racial, Ethnic Inequities Persist in Diabetes Care
Significant differences in the use of insulin pump and/or CGM technology were noted based on demographic and socioeconomic factors
FDA Clears First Commercially Available Blood Test to Evaluate for TBI, Concussion
The test is intended to complement the company’s TBI plasma test, which received FDA clearance in 2021.
FDA Sets Target Date To Expand Dwarfism Care Voxzogo To Younger Children
Voxzogo is already available for patients over 5 years with a genetic cause of dwarfism. The PDUFA date is set for Oct. 21, 2023, and will potentially expand the drug to children 5 and under.
FDA Accepts Biologics License Application for Proposed Denosumab Biosimilar
The drug, manufactured by Sandoz, will treat conditions including osteoporosis in postmenopausal women
Show Them The Money
The role of the pharmacy technician has evolved over the past 45 years—but pay hasn’t caught up
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
